Page last updated: 2024-10-24

RNA-DNA hybrid ribonuclease activity

Definition

Target type: molecularfunction

Catalysis of the endonucleolytic cleavage of RNA in RNA-DNA hybrids to 5'-phosphomonoesters. [EC:3.1.26.4]

RNA-DNA hybrid ribonuclease activity involves the enzymatic hydrolysis of phosphodiester bonds within RNA molecules that are hybridized to DNA. This activity is crucial for several biological processes, including:

- **DNA repair:** RNA-DNA hybrids can form during DNA replication and repair processes, acting as substrates for these enzymes. Their degradation by RNA-DNA hybrid ribonucleases helps to maintain genomic integrity by removing aberrant RNA sequences that could interfere with DNA replication or repair.

- **Gene regulation:** RNA-DNA hybrids can form during transcription, and their presence can influence gene expression. RNA-DNA hybrid ribonucleases can regulate transcription by degrading these hybrids, thus modulating the level of gene expression.

- **Viral replication:** Some viruses, including retroviruses, use RNA-DNA hybrids as intermediates in their replication cycle. RNA-DNA hybrid ribonucleases can interfere with viral replication by degrading these hybrids, thus inhibiting viral growth.

- **Immune response:** RNA-DNA hybrids can also be involved in immune responses, as they can activate innate immune pathways. RNA-DNA hybrid ribonucleases can play a role in regulating these responses by degrading these hybrids and preventing excessive activation of the immune system.

- **Recombination and repair:** RNA-DNA hybrid ribonucleases participate in various DNA repair and recombination processes. For example, in homologous recombination, these enzymes can degrade invading RNA sequences to prevent aberrant recombination events.

The molecular mechanism of RNA-DNA hybrid ribonuclease activity involves the specific recognition and binding of RNA-DNA hybrids, followed by the hydrolysis of the phosphodiester bond within the RNA strand. The precise mechanism of substrate recognition and cleavage can vary depending on the specific enzyme, but typically involves the formation of a complex between the enzyme, the RNA-DNA hybrid, and divalent metal ions like magnesium.

The activity of RNA-DNA hybrid ribonucleases is tightly regulated to ensure proper cellular function. These enzymes are often expressed in a tissue-specific manner, and their activity can be modulated by various factors, including post-translational modifications, interactions with other proteins, and cellular stress responses.

Disruptions in RNA-DNA hybrid ribonuclease activity can have significant consequences for cellular health and have been linked to various diseases, including cancer, autoimmune disorders, and viral infections.'
"

Proteins (4)

ProteinDefinitionTaxonomy
Ribonuclease HIA ribonuclease HI that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0A7Y4]Escherichia coli K-12
Flap endonuclease 1A flap endonuclease 1 that is encoded in the genome of human. [PRO:DNx]Homo sapiens (human)
DNA-(apurinic or apyrimidinic site) endonucleaseA DNA-(apurinic or apyrimidinic site) endonuclease that is encoded in the genome of human. [PRO:DNx, UniProtKB:P27695]Homo sapiens (human)
Ribonuclease H1A ribonuclease H1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60930]Homo sapiens (human)

Compounds (27)

CompoundDefinitionClassesRoles
aurintricarboxylic acidaurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'.

Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.
monohydroxybenzoic acid;
quinomethanes;
tricarboxylic acid
fluorochrome;
histological dye;
insulin-like growth factor receptor 1 antagonist
hycanthonehycanthone : A thioxanthen-9-one compound having a hydroxymethyl substituent at the 1-position and a 2-[(diethylamino)ethyl]amino substituent at the 4-position. It was formerly used (particularly as the monomethanesulfonic acid salt) as a schistosomicide for individual or mass treatement of infection with Schistosoma haematobium and S. mansoni, but due to its toxicity and concern about possible carcinogenicity, it has been replaced by other drugs such as praziquantel.

Hycanthone: Potentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE.
thioxanthenesmutagen;
schistosomicide drug
lucanthonelucanthone : A thioxanthen-9-one compound having a methyl substituent at the 1-position and a 2-[(diethylamino)ethyl]amino substituent at the 4-position. Formerly used for the treatment of schistosomiasis. It is a prodrug, being metabolised to hycanthone.

Lucanthone: One of the SCHISTOSOMICIDES, it has been replaced largely by HYCANTHONE and more recently PRAZIQUANTEL. (From Martindale The Extrapharmacopoeia, 30th ed., p46)
thioxanthenesadjuvant;
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
mutagen;
photosensitizing agent;
prodrug;
schistosomicide drug
mitoxantrone hydrochloridehydrochlorideantineoplastic agent
gallocatechol(-)-epigallocatechin : A flavan-3,3',4',5,5',7-hexol having (2R,3R)-configuration.catechin;
flavan-3,3',4',5,5',7-hexol
antioxidant;
food component;
plant metabolite
beta-thujaplicinolbeta-thujaplicinol: inhibits ribonuclease H activity of HIV-1 reverse transcriptase; structure in first source
7-nitro-1h-indole-2-carboxylic acid7-nitro-1H-indole-2-carboxylic acid: acts on AP endonuclease, 3'-phosphodiesterase, and 3'-phosphatase activities of APE1; structure in first source
n-hydroxynaphthalimideN-hydroxynaphthalimide: structure in first source
3,3',4,4',5,5'-hexabromobiphenyl
6-hydroxydopa6-hydroxydopa: RN given refers to cpd without isomeric designationnon-proteinogenic alpha-amino acid
rhodiolosideglycoside
tanshinone ii atashinone IIA: a cardiovascular agent with antineoplastic activity; isolated from Salvia miltiorrhiza; structure in first sourceabietane diterpenoid
3-hydroxy-quinazoline-2,4-dione3-hydroxy-quinazoline-2,4-dione: structure in first source
1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dionepyrimidotriazine
4-phenyl-4-oxo-2-hydroxybuten-2-oic acid2,4-dioxo-4-phenylbutanoic acid: structure in first source
2-hydroxy-4h-isoquinoline-1,3-dione2-hydroxy-4H-isoquinoline-1,3-dione: structure in first source
nsc 727447NSC 727447: structure in first source
2-[[5-(dimethylsulfamoyl)-1H-indol-3-yl]methylidene]propanedioic acid diethyl esterindoles
1,6-dimethyl-3-propylpyrimido[5,4-e][1,2,4]triazine-5,7-dionepyrimidotriazine
myricetin7-hydroxyflavonol;
hexahydroxyflavone
antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
syringinsyringin : A monosaccharide derivative that is trans-sinapyl alcohol attached to a beta-D-glucopyranosyl residue at position 1 via a glycosidic linkage.

syringin: a phenylpropanoid glycoside; see also eleutherosides & lyoniside for eleutheroside A: 474-58-8
beta-D-glucoside;
dimethoxybenzene;
monosaccharide derivative;
primary alcohol
hepatoprotective agent;
plant metabolite
ag 538AG 538: an IGF-1 receptor kinase inhibitor; structure in first source
e 3330E 3330: structure given in first source; MW 378.47
methyl chlorogenatemethyl chlorogenate: from Eriobotrya japonica; structure in first sourcequinic acid
N-[3-(1,3-benzothiazol-2-yl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-2-yl]acetamidebenzothiazoles
thiolactomycinthiolactomycin: from actinomycetes; structure given in first source
galloflavingalloflavin: structure in first source